A. Alexopoulos

Democritus University of Thrace — Greece

Medicine · Health Sciences

14h-index1.2kcitations55works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(24), Breast Cancer Treatment Studies(11), HER2/EGFR in Cancer Research(10), Advanced Breast Cancer Therapies(8), Neutropenia and Cancer Infections(6)

Publications55 total

Microbiological stability and sensorial valorization of thyme and oregano essential oils alone or combined with ethanolic pomegranate extracts in wine marinated pork meat
International Journal of Food Microbiology·2022· 15 cited
Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)
Anticancer Research·2022· 5 cited
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab
Oncology Letters·2021· 3 citedOpen Access
Parametric Evaluation Of Collaborative Filtering Over Apache Spark
2020· 10 cited
ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer
Breast Cancer Research and Treatment·2020· 4 cited
Contraception After Bariatric Surgery
Deutsches Ärzteblatt international·2020Open Access
Two-Step Classification with SVD Preprocessing of Distributed Massive Datasets in Apache Spark
Algorithms·2020· 19 citedOpen Access
Abstract P2-15-07: Real-world multicenter, prospective study of the effects of <i>nab</i>-paclitaxel on clinical outcomes and quality of life of patients with metastatic breast cancer in Greece. The ‘ABReast’ study
Cancer Research·2020
Current Trends in Balsamic/Aged Vinegar Production and Research
2019· 2 cited
Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer– A Single Centre Prospective Observational Study
In Vivo·2018· 30 citedOpen Access
Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
Breast Cancer Basic and Clinical Research·2018· 12 citedOpen Access
Incremental Learning for Large Scale Classification Systems
IFIP advances in information and communication technology·2018· 5 citedOpen Access
Rationale and design of the real-world Hellenic disease management patterns with everolimus for women with hormone-receptor-positive, human epidermal growth factor ReceptOR-2 negative advanced breast cancer (The MIRROR) study
The Breast·2017Open Access
フェタ型チーズから分離したLactobacillus株のプロバイオティックポテンシャルの単離,特性化と評価【Powered by NICT】
Food Chemistry·2017
Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
Molecular Imaging and Radionuclide Therapy·2016· 2 citedOpen Access
Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study
BMC Health Services Research·2015· 10 citedOpen Access
Antimicrobial activity of essential oils of cultivated oregano (<i>Origanum vulgare</i>), sage (<i>Salvia officinalis</i>), and thyme (<i>Thymus vulgaris</i>) against clinical isolates of<i>Escherichia coli</i>,<i>Klebsiella oxytoca</i>, and<i>Klebsiella pneumoniae</i>
Microbial Ecology in Health and Disease·2015· 144 citedOpen Access
Prevalence, genetic diversity, and antimicrobial susceptibility profiles of Staphylococcus aureus isolated from bulk tank milk from Greek traditional ovine farms
Small Ruminant Research·2015· 29 cited
Cost Effectiveness Analysis of Everolimus Plus Exemestane Vs. Bevacizumab Plus Paclitaxel and Bevacizumab Plus Capecitabine for the Management of Postmenopausal Women with Er+ Breast Cancer
Annals of Oncology·2014· 1 citedOpen Access
Economic evaluation of everolimus plus exemestane versus bevacizumab plus paclitaxel and bevacizumab plus capecitabine for the management of postmenopausal women with ER+ breast cancer.
Journal of Clinical Oncology·2014· 1 cited
page 1 of 3Next →

Frequent Co-authors

G. Rigatos(15), Alexandros Ardavanis(10), Sofia Agelaki(8), Nikolaos Malamos(7), Ch. Kouroussis(7), Eugenia Bezirtzoglou(6), Stavros Plessas(5), C. Kandylis(5), M. V. Karamouzis(5), K. Kalbakis(4), S. Kakolyris(4), V. Georgoulias(4), Dimitrios Tryfonopoulos(4), J. Stavrakakis(4), Vasiliki Rapti(4), G. Koumakis(4), Chrysoula Voidarou(4), Vassilis Georgoulias(3), Michalis Leotsinidis(3), Ioanna Mantzourani(3)